位置:首页 > 蛋白库 > FLRT1_MOUSE
FLRT1_MOUSE
ID   FLRT1_MOUSE             Reviewed;         646 AA.
AC   Q6RKD8; Q14DT7; Q6RKD9;
DT   14-OCT-2015, integrated into UniProtKB/Swiss-Prot.
DT   13-FEB-2019, sequence version 2.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Leucine-rich repeat transmembrane protein FLRT1;
DE   AltName: Full=Fibronectin leucine rich transmembrane protein 1 {ECO:0000312|EMBL:AAR92201.1};
DE   Flags: Precursor;
GN   Name=Flrt1 {ECO:0000312|MGI:MGI:3026647};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000312|EMBL:AAR92201.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH FGFR1, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, DEVELOPMENTAL STAGE, AND INDUCTION BY FGF2.
RC   STRAIN=C57BL/6 X DBA/2J {ECO:0000312|EMBL:AAR92201.1};
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAR92201.1};
RX   PubMed=16872596; DOI=10.1016/j.ydbio.2006.04.004;
RA   Haines B.P., Wheldon L.M., Summerbell D., Heath J.K., Rigby P.W.J.;
RT   "Regulated expression of FLRT genes implies a functional role in the
RT   regulation of FGF signalling during mouse development.";
RL   Dev. Biol. 297:14-25(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=18448090; DOI=10.1016/j.ydbio.2008.03.021;
RA   Maretto S., Mueller P.S., Aricescu A.R., Cho K.W., Bikoff E.K.,
RA   Robertson E.J.;
RT   "Ventral closure, headfold fusion and definitive endoderm migration defects
RT   in mouse embryos lacking the fibronectin leucine-rich transmembrane protein
RT   FLRT3.";
RL   Dev. Biol. 318:184-193(2008).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-572; TYR-605 AND
RP   TYR-643, AND MUTAGENESIS OF TYR-572; TYR-605 AND TYR-643.
RX   PubMed=20421966; DOI=10.1371/journal.pone.0010264;
RA   Wheldon L.M., Haines B.P., Rajappa R., Mason I., Rigby P.W., Heath J.K.;
RT   "Critical role of FLRT1 phosphorylation in the interdependent regulation of
RT   FLRT1 function and FGF receptor signalling.";
RL   PLoS ONE 5:E10264-E10264(2010).
RN   [8]
RP   SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND GLYCOSYLATION.
RX   PubMed=21673655; DOI=10.1038/emboj.2011.189;
RA   Yamagishi S., Hampel F., Hata K., Del Toro D., Schwark M., Kvachnina E.,
RA   Bastmeyer M., Yamashita T., Tarabykin V., Klein R., Egea J.;
RT   "FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive
RT   neurons.";
RL   EMBO J. 30:2920-2933(2011).
RN   [9]
RP   FUNCTION, INTERACTION WITH ADGRL1 AND ADGRL3, AND SUBCELLULAR LOCATION.
RX   PubMed=22405201; DOI=10.1016/j.neuron.2012.01.018;
RA   O'Sullivan M.L., de Wit J., Savas J.N., Comoletti D., Otto-Hitt S.,
RA   Yates J.R. III, Ghosh A.;
RT   "FLRT proteins are endogenous latrophilin ligands and regulate excitatory
RT   synapse development.";
RL   Neuron 73:903-910(2012).
CC   -!- FUNCTION: Plays a role in fibroblast growth factor-mediated signaling
CC       cascades that lead to the activation of MAP kinases (PubMed:16872596,
CC       PubMed:20421966). Promotes neurite outgrowth via FGFR1-mediated
CC       activation of downstream MAP kinases. Promotes an increase both in
CC       neurite number and in neurite length (PubMed:20421966). May play a role
CC       in cell-cell adhesion and cell guidance via its interaction with
CC       ADGRL1/LPHN1 and ADGRL3 (PubMed:22405201).
CC       {ECO:0000269|PubMed:16872596, ECO:0000269|PubMed:20421966,
CC       ECO:0000305|PubMed:22405201}.
CC   -!- SUBUNIT: Interacts with FGFR1 (PubMed:16872596). Interacts (via
CC       extracellular domain) with ADGRL1/LPHN1 and ADGRL3 (via olfactomedin-
CC       like domain) (PubMed:22405201). {ECO:0000269|PubMed:16872596,
CC       ECO:0000269|PubMed:22405201}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16872596,
CC       ECO:0000269|PubMed:20421966, ECO:0000269|PubMed:22405201}; Single-pass
CC       membrane protein {ECO:0000305}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:16872596, ECO:0000305|PubMed:20421966}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:16872596,
CC       ECO:0000269|PubMed:20421966}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:16872596, ECO:0000269|PubMed:20421966}. Cell
CC       junction, focal adhesion {ECO:0000269|PubMed:16872596}. Secreted
CC       {ECO:0000269|PubMed:21673655}. Cell projection, neuron projection
CC       {ECO:0000269|PubMed:20421966}. Cell junction
CC       {ECO:0000269|PubMed:20421966}. Note=In addition to its location at the
CC       cell membrane, colocalizes with FGFR1 in punctate perinuclear
CC       cytoplasmic vesicles (PubMed:16872596, PubMed:20421966). Detected along
CC       neurites and at contacts between neurite termini and other cells
CC       (PubMed:20421966). Proteolytic cleavage gives rise to a shedded
CC       ectodomain (PubMed:21673655). {ECO:0000269|PubMed:16872596,
CC       ECO:0000269|PubMed:20421966, ECO:0000269|PubMed:21673655}.
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level).
CC       {ECO:0000269|PubMed:21673655}.
CC   -!- DEVELOPMENTAL STAGE: Detected at comparable levels in embryonic brain
CC       and in brain from ten day old animals (at protein level)
CC       (PubMed:16872596). Detected in neuroectoderm at 7.5 dpc. Detected in
CC       midbrain between 8.5 and 9 dpc (PubMed:18448090). Detected at 9.5 dpc
CC       in embryonic midbrain adjacent to the boundary between midbrain and
CC       forebrain (PubMed:16872596). At 10.5 dpc, expression is also detected
CC       in the eye, throughout the brain, the dorsal root ganglia and
CC       trigeminal ganglia, and in cells adjacent to the urogenital ridge in
CC       the torso (PubMed:16872596, PubMed:18448090). At 11 dpc, expression in
CC       midbrain is tightly restricted to the boundary between midbrain and
CC       hindbrain (PubMed:16872596). {ECO:0000269|PubMed:16872596}.
CC   -!- INDUCTION: Up-regulated by FGF2. {ECO:0000269|PubMed:16872596}.
CC   -!- PTM: Phosphorylated in response to FGFR1 signaling, but is not a direct
CC       substrate of FGFR1 or SRC. A mutant where the Tyr phosphorylation sites
CC       have been replaced by Phe displays constitutive FGFR1-dependent
CC       activation of downstream MAP kinases. {ECO:0000269|PubMed:20421966}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16872596,
CC       ECO:0000269|PubMed:21673655}.
CC   -!- PTM: Proteolytic cleavage in the juxtamembrane region gives rise to a
CC       soluble ectodomain. {ECO:0000269|PubMed:21673655}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH70403.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI11880.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI12384.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI38215.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAR92201.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAE20477.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=EDL33290.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY495667; AAR92200.1; -; mRNA.
DR   EMBL; AY495668; AAR92201.1; ALT_INIT; mRNA.
DR   EMBL; AK031503; BAE20477.1; ALT_INIT; mRNA.
DR   EMBL; AC109619; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466612; EDL33290.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC070403; AAH70403.1; ALT_INIT; mRNA.
DR   EMBL; BC111879; AAI11880.1; ALT_INIT; mRNA.
DR   EMBL; BC112383; AAI12384.1; ALT_INIT; mRNA.
DR   EMBL; BC138214; AAI38215.1; ALT_INIT; mRNA.
DR   RefSeq; NP_958813.1; NM_201411.2.
DR   RefSeq; XP_006527232.1; XM_006527169.2.
DR   RefSeq; XP_006527233.1; XM_006527170.3.
DR   RefSeq; XP_006527234.1; XM_006527171.3.
DR   AlphaFoldDB; Q6RKD8; -.
DR   SMR; Q6RKD8; -.
DR   STRING; 10090.ENSMUSP00000109010; -.
DR   GlyConnect; 2475; 1 N-Linked glycan (1 site).
DR   GlyGen; Q6RKD8; 2 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; Q6RKD8; -.
DR   PhosphoSitePlus; Q6RKD8; -.
DR   PaxDb; Q6RKD8; -.
DR   PRIDE; Q6RKD8; -.
DR   ProteomicsDB; 273002; -.
DR   DNASU; 396184; -.
DR   GeneID; 396184; -.
DR   KEGG; mmu:396184; -.
DR   UCSC; uc008gkh.3; mouse.
DR   CTD; 23769; -.
DR   MGI; MGI:3026647; Flrt1.
DR   eggNOG; ENOG502QWDS; Eukaryota.
DR   HOGENOM; CLU_027624_0_0_1; -.
DR   InParanoid; Q6RKD8; -.
DR   OrthoDB; 826997at2759; -.
DR   PhylomeDB; Q6RKD8; -.
DR   TreeFam; TF331598; -.
DR   Reactome; R-MMU-5654687; Downstream signaling of activated FGFR1.
DR   BioGRID-ORCS; 396184; 2 hits in 74 CRISPR screens.
DR   ChiTaRS; Flrt1; mouse.
DR   PRO; PR:Q6RKD8; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q6RKD8; protein.
DR   Genevisible; Q6RKD8; MM.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044306; C:neuron projection terminus; IDA:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005104; F:fibroblast growth factor receptor binding; IPI:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016358; P:dendrite development; IMP:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:1990138; P:neuron projection extension; IMP:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IDA:MGI.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   Pfam; PF13855; LRR_8; 3.
DR   Pfam; PF01462; LRRNT; 1.
DR   SMART; SM00369; LRR_TYP; 8.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00013; LRRNT; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell junction; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoplasmic vesicle; Developmental protein; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Leucine-rich repeat; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..646
FT                   /note="Leucine-rich repeat transmembrane protein FLRT1"
FT                   /id="PRO_0000434522"
FT   TOPO_DOM        24..524
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        525..545
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        546..646
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          26..52
FT                   /note="LRRNT"
FT                   /evidence="ECO:0000255"
FT   REPEAT          53..77
FT                   /note="LRR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          78..98
FT                   /note="LRR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          99..121
FT                   /note="LRR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          123..147
FT                   /note="LRR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          148..169
FT                   /note="LRR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          170..192
FT                   /note="LRR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          194..218
FT                   /note="LRR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          219..241
FT                   /note="LRR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          242..264
FT                   /note="LRR 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          265..288
FT                   /note="LRR 10"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          300..351
FT                   /note="LRRCT"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          409..504
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOD_RES         572
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:20421966"
FT   MOD_RES         605
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:20421966"
FT   MOD_RES         643
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:20421966"
FT   CARBOHYD        277
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        26..32
FT                   /evidence="ECO:0000250|UniProtKB:Q8BGT1"
FT   DISULFID        30..39
FT                   /evidence="ECO:0000250|UniProtKB:Q8BGT1"
FT   DISULFID        304..329
FT                   /evidence="ECO:0000250|UniProtKB:Q8BGT1"
FT   MUTAGEN         572
FT                   /note="Y->F: Decreases phosphorylation. Nearly abolishes
FT                   phosphorylation; when associated with F-605 and F-643."
FT                   /evidence="ECO:0000269|PubMed:20421966"
FT   MUTAGEN         605
FT                   /note="Y->F: Decreases phosphorylation. Nearly abolishes
FT                   phosphorylation; when associated with F-572 and F-643."
FT                   /evidence="ECO:0000269|PubMed:20421966"
FT   MUTAGEN         643
FT                   /note="Y->F: Decreases phosphorylation. Nearly abolishes
FT                   phosphorylation; when associated with F-572 and F-605."
FT                   /evidence="ECO:0000269|PubMed:20421966"
FT   CONFLICT        453
FT                   /note="T -> I (in Ref. 5; AAI11880)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   646 AA;  71492 MW;  628B5CAEF3D88E5E CRC64;
     MDLRDWLFLC YGLIAFLTEV IDSTTCPSVC RCDNGFIYCN DRGLTSIPSD IPDDATTLYL
     QNNQINNAGI PQDLKTKVKV QVIYLYENDL DEFPINLPRS LRELHLQDNN VRTIARDSLA
     RIPLLEKLHL DDNSVSTVSI EEDAFADSKQ LKLLFLSRNH LSSIPSGLPH TLEELRLDDN
     RISTIPLHAF KGLNSLRRLV LDGNLLANQR IADDTFSRLQ NLTELSLVRN SLAAPPLNLP
     SAHLQKLYLQ DNAISHIPYN TLAKMRELER LDLSNNNLTT LPRGLFDDLG NLAQLLLRNN
     PWFCGCNLMW LRDWVRARAA VVNVRGLMCQ GPEKVRGMAI KDITSEMDEC FEAGSQGGAA
     NAAAKTTVSN HASATTPQGS LFTLKAKRPG LRLPDSNIDY PMATGDGAKT LVIQVKPLTA
     DSIRITWKAM LPASSFRLSW LRLGHSPAVG SITETLVQGD KTEYLLTALE PKSTYIICMV
     TMETGNTYVA DETPVCAKAE TADSYGPTTT LNQEQNAGPM AGLPLAGIIG GAVALVFLFL
     VLGAICWYVH RAGELLTRER VYNRGSRRKD DYMESGTKKD NSILEIRGPG LQMLPINPYR
     SKEEYVVHTI FPSNGSSLCK GAHTIGYGTT RGYREAGIPD VDYSYT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024